Alek Dragovic

Aleksandar F Dragovic, MD

Clinical Assistant Professor
7500 Challis Rd
Brighton, MI 48116
810-263-4000

Administrative Contact

Kelley Coppola 734-936-7810

Biography

Dr. Dragovic attended the University of Michigan for both undergraduate and medical school, and after completing radiation oncology residency at the University of Alabama at Birmingham (UAB), he returned to Ann Arbor to join the U of M Department of Radiation Oncology faculty in 2012. Since that time, he has held several roles in the Department of Radiation Oncology, with experience in multiple of the department’s community practice affiliates as well as at the main hospital. Dr. Dragovic was chosen to lead the department’s new clinic at the Brighton Center for Specialty Care and also to represent the BCSC Cancer Center as a whole as Physician Lead.  He has taken on these roles with great joy and pride as it has been both a challenge and reward being a part of building a new cancer center.  Dr. Dragovic’s vision for the BCSC Cancer Center is to become more or less an extension of the University Hospital Cancer Center- providing the highest quality multidisciplinary care to patients with a wide variety of cancer diagnoses, including the availability of clinical trial enrollment for appropriate patients. Clinically, Dr. Dragovic treats all disease sites and has a specific clinical interest in head & neck cancer, lung cancer, and stereotactic body radiotherapy (SBRT).

Areas of Interest

  • Head and neck cancer
  • Altered fractionation of radiation therapy

Clinical Interests

  • Head and neck cancer, lung cancer
  • Stereotactic radiotherapy
  • Quality improvement in multidisciplinary cancer care

Credentials

  • MD, University of Michigan Medical School, 2007
  • Residency, University of Alabama Hospitals, Radiation Oncology, AL, 2012
  • Board Certification: Radiation Oncology

Published Articles or Reviews

Selected from 5 publications

  • Dragovic AF, Bonner JA, Spencer SA, Nabell LM, Carroll WR, Caudell JJ. Impact of average weekly dose of radiation during radiotherapy alone or chemoradiotherapy in head and neck cancer. Head & Neck/ 33(11):1551-6, 2011. PM21990218
  • Dragovic AF, Caudell JJ, Spencer SA, Carroll WR, Nabell LA, Bonner JA. Locoregional failure and the risk of distant metastasis after modern radiotherapy for head and neck cancer. Head & Neck. 2012. PM22407986
  • Kim RY, Dragovic AF, Whitley AC, Shen S. Image-guided brachytherapy for cervical cancer: Analysis of D2cc hot spot in three-dimensional and anatomic factors affecting D2cc hot spot in organs at risk. Brachytherapy. 13(2):203-209, 2014. PM23953809
Locations

7500 Challis Rd

Brighton, MI  48116

810-263-4000